Carmen J. Tartari

Bergamo, 24127, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During Chemotherapy.

Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During Chemotherapy.

Journal: Cancers

Published: July 14, 2025

Thromboinflammatory Biomarkers Are Early Predictors of Disease Progression in Non-Small Cell Lung Cancer Patients.

Thromboinflammatory Biomarkers Are Early Predictors of Disease Progression in Non-Small Cell Lung Cancer Patients.

Journal: Cancers

Published: April 22, 2025

Activated factor XI-antithrombin and thrombin-antithrombin complexes in the prediction of venous thromboembolism and mortality in patients with non-small-cell lung cancer.

Activated factor XI-antithrombin and thrombin-antithrombin complexes in the prediction of venous thromboembolism and mortality in patients with non-small-cell lung cancer.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 16, 2024

A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients.

A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients.

Journal: Cancers

Published: August 14, 2023

Hemostatic Profile and Serological Response of Patients with Immune Thrombotic Thrombocytopenic Purpura after Receiving BNT162b2 Vaccine: A Prospective Study.

Hemostatic Profile and Serological Response of Patients with Immune Thrombotic Thrombocytopenic Purpura after Receiving BNT162b2 Vaccine: A Prospective Study.

Journal: Thrombosis and haemostasis

Published: May 12, 2023

Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort.

Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort.

Journal: Journal of thrombosis and haemostasis : JTH

Published: September 29, 2022

Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal Cancer.

Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal Cancer.

Journal: Cancers

Published: July 04, 2022

Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease Recurrence.

Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease Recurrence.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: September 23, 2020

Thrombin generation predicts early recurrence in breast cancer patients.

Thrombin generation predicts early recurrence in breast cancer patients.

Journal: Journal of thrombosis and haemostasis : JTH

Published: November 26, 2019

Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer.

Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer.

Journal: Haematologica

Published: June 07, 2019

Long Term Low Molecular Weight Heparin Anticoagulant Therapy Modulates Thrombin Generation and D-dimer in Patients with Cancer and Venous Thromboembolism.

Long Term Low Molecular Weight Heparin Anticoagulant Therapy Modulates Thrombin Generation and D-dimer in Patients with Cancer and Venous Thromboembolism.

Journal: Cancer investigation

Published: July 11, 2017

Platelet haemostatic properties in β-thalassaemia: the effect of blood transfusion.

Platelet haemostatic properties in β-thalassaemia: the effect of blood transfusion.

Journal: Blood transfusion = Trasfusione del sangue

Published: February 05, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026